Starpharma Holdings Limited
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-11.93-100.36-162.31-430.03-365.27-298.63-300.26-173.29-82.43-44.94N/A-365.27
Price/Sales ratio
281.35604.13893.231.16K3.15K726.573.29K597.91438.6037.61N/A726.57
Price/Book Value ratio
6.0246.0443.8283.01122.81139.9295.1057.8437.0213.05N/A139.92
Price/Cash Flow ratio
-16.61-127.77-157.62-433.57-503.34-406.77-400.10-212.69-95.25-52.60N/A-503.34
Price/Free Cash Flow ratio
-15.85-127.08-152.02-418.83-488.51-402.11-393.56-199.97-91.07-51.94N/A-488.51
Price/Earnings Growth ratio
-0.601.125.0711.37-9.57-114.67-11.488.6121.810.94N/A-9.57
Dividend Yield
0.01%0.05%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%101.53%100%100%66.74%70.14%30.00%40.70%41.59%-9.52%N/A70.14%
Operating Profit Margin
-2356.34%-671.94%-638.50%-406.24%-1235.25%-355.19%-1594.49%-510.35%-839.50%-243.38%N/A-1235.25%
Pretax Profit Margin
-2356.96%-650.73%-617.27%-376.20%-1170.50%-337.26%-1500.55%-500.10%-791.73%-83.69%N/A-1170.50%
Net Profit Margin
-2356.96%-601.93%-550.30%-269.80%-863.35%-243.29%-1097.44%-345.02%-532.08%-83.69%N/A-863.35%
Effective Tax Rate
-0.04%13.13%17.60%28.28%26.24%27.86%26.86%31.00%32.79%N/AN/A27.86%
Return on Assets
-42.69%-38.40%-24.72%-17.57%-29.17%-37.56%-26.94%-24.41%-30.02%-22.17%N/A-29.17%
Return On Equity
-50.45%-45.87%-26.99%-19.30%-33.62%-46.85%-31.67%-33.38%-44.91%-29.04%N/A-33.62%
Return on Capital Employed
-50.36%-51.17%-31.28%-29.02%-48.06%-66.17%-45.64%-42.71%-65.59%-78.75%N/A-48.06%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.92N/A
Quick Ratio
5.185.2511.8911.127.375.406.615.653.064.575.645.40
Cash ratio
4.554.8011.089.936.414.485.804.872.433.504.874.48
Days of Sales Outstanding
1.75K381.56468.20583.781.34K368.261.71K610.871.02K21.25N/A368.26
Days of Inventory outstanding
N/AN/AN/AN/A265.27100.11499.13371.31589.6582.25N/A100.11
Operating Cycle
N/A381.56N/AN/A1.60K468.382.21K982.191.61K103.50N/A468.38
Days of Payables Outstanding
N/A-51.66KN/AN/A2.72K890.511.94K889.091.40K93.08N/A890.51
Cash Conversion Cycle
N/A52.04KN/AN/A-1.11K-422.12265.9093.09205.7410.42N/A-1.11K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.060.090.020.26N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A0.080.130.020.36N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.07N/AN/A0.13N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.070.120.020.14N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A17.81MN/AN/AN/AN/AN/A-3.29-2.83-9.00N/AN/A
Company Equity Multiplier
1.181.191.091.091.151.241.171.361.491.301.361.15
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-16.93-4.72-5.66-2.67-6.26-1.78-8.23-2.81-4.60-0.71N/A-6.26
Free Cash Flow / Operating Cash Flow Ratio
1.041.001.031.031.031.011.011.061.041.01N/A1.01
Cash Flow Coverage Ratio
N/A17.81MN/AN/AN/AN/AN/A-3.29-2.83-9.00N/AN/A
Short Term Coverage Ratio
N/A17.81MN/AN/AN/AN/AN/AN/A-2.83-9.00N/AN/A
Dividend Payout Ratio
-0.16%-5.95%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A